AVEO Oncology
AVEO
#7201
Rank
โ‚น48.54 B
Marketcap
โ‚น1,397
Share price
0.00%
Change (1 day)
192.98%
Change (1 year)

Earnings for AVEO Oncology (AVEO)

Earnings in 2022 (TTM): -โ‚น2.24 Billion

According to AVEO Oncology 's latest financial reports the company's current earnings are โ‚น94.31 Million. In 2021 the company made an earning of -โ‚น4.97 Billion a decrease over its 2020 earnings that were of -โ‚น3.32 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AVEO Oncology from 2009 to 2022

Annual earnings

Year Earnings Change
2022 (TTM) -โ‚น2.24 Billion-54.96%
2021 -โ‚น4.97 Billion49.9%
2020 -โ‚น3.32 Billion-479.04%
2019 โ‚น0.87 B-276.17%
2018 -โ‚น0.5 Billion-91.79%
2017 -โ‚น6.05 Billion142.38%
2016 -โ‚น2.5 Billion78.51%
2015 -โ‚น1.4 Billion-71.55%
2014 -โ‚น4.92 Billion-50.72%
2013 -โ‚น9.97 Billion-4.88%
2012 -โ‚น10.48 Billion-426.29%
2011 โ‚น3.21 B-159.85%
2010 -โ‚น5.37 Billion35.33%
2009 -โ‚น3.97 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Eli Lilly
LLY
โ‚น2.395 T-88,708.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น835.71 B-31,010.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น144.91 B-5,460.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚น487.00 B-18,112.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น868.49 B-32,222.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
-โ‚น0.22 Billion-92.22%๐Ÿ‡บ๐Ÿ‡ธ USA